AIMS: To compare in a randomised trial the safety and efficacy of the FemoSeal vascular closure device (VCD) versus manual compression (MC) after femoral access coronary angiography (CAG). METHODS AND RESULTS: In 13 months, 1,014 patients were included and 1,001 patients entered analysis. Median [interquartile range] closure time was 8.0 [6-10] minutes after MC versus 1.0 [1-1] minute (p<0.0001) for the FemoSeal VCD. Bed rest for one hour after the closure procedure was recommended in both groups. The primary endpoint of incidence of large groin haematoma was 6.7% in the MC group vs. 2.2% (p=0.002) in the FemoSeal group. The combined endpoint of 14-day adverse vascular events occurred in 1.0% in the MC group vs. 0.6% in the FemoSeal VCD group (p=0.7). Manual compression (OR 3.3, 95% CI: 1.5-7.2, p=0.002), female gender (OR 2.1, 95% CI: 1.1-3.9, p=0.018), and multiple punctures (OR 10.5, 95% CI: 3.2-34.3, p=0.001) were identified as independent predictors of adverse events and large haematomas. CONCLUSIONS: Closure of femoral access after coronary angiography by the FemoSeal vascular closure device was safe, faster, and associated with significantly fewer in-hospital large haematomas as compared to closure by manual compression.
RCT Entities:
AIMS: To compare in a randomised trial the safety and efficacy of the FemoSeal vascular closure device (VCD) versus manual compression (MC) after femoral access coronary angiography (CAG). METHODS AND RESULTS: In 13 months, 1,014 patients were included and 1,001 patients entered analysis. Median [interquartile range] closure time was 8.0 [6-10] minutes after MC versus 1.0 [1-1] minute (p<0.0001) for the FemoSeal VCD. Bed rest for one hour after the closure procedure was recommended in both groups. The primary endpoint of incidence of large groin haematoma was 6.7% in the MC group vs. 2.2% (p=0.002) in the FemoSeal group. The combined endpoint of 14-day adverse vascular events occurred in 1.0% in the MC group vs. 0.6% in the FemoSeal VCD group (p=0.7). Manual compression (OR 3.3, 95% CI: 1.5-7.2, p=0.002), female gender (OR 2.1, 95% CI: 1.1-3.9, p=0.018), and multiple punctures (OR 10.5, 95% CI: 3.2-34.3, p=0.001) were identified as independent predictors of adverse events and large haematomas. CONCLUSIONS: Closure of femoral access after coronary angiography by the FemoSeal vascular closure device was safe, faster, and associated with significantly fewer in-hospital large haematomas as compared to closure by manual compression.
Authors: Michael Sacherer; Ewald Kolesnik; Friederike von Lewinski; Nicolas Verheyen; Karin Brandner; Markus Wallner; Deborah M Eaton; Olev Luha; Robert Zweiker; Dirk von Lewinski Journal: Cardiol J Date: 2018-04-03 Impact factor: 2.737
Authors: Johannes Ketterle; Harald Rittger; Inga Helmig; Lutz Klinghammer; Stefan Zimmermann; Wolfgang Hohenforst-Schmidt; Johannes Brachmann; Holger Nef; Stephan Achenbach; Christian Schlundt Journal: Herz Date: 2015-06-13 Impact factor: 1.443
Authors: Christoph Brenner; Julian Margreitter; Alexandra Gratl; Josef Klocker; Rudolf Kirchmair; Peter Marschang; Guy Friedrich; Bernhard Metzler; Nicolas Moes Journal: Wien Klin Wochenschr Date: 2018-01-24 Impact factor: 1.704
Authors: Lars Jakobsen; Niels R Holm; Michael Maeng; Troels Thim; Steen D Kristensen; Lone H Mogensen; Evald H Christiansen Journal: BMC Cardiovasc Disord Date: 2022-02-23 Impact factor: 2.298